Comparison of demographics, clinical data, imaging data, EVT parameters, and outcomes between the LVO and MeVO cohorts. Regression analysis for associations with 90-day mRS.
| LVO (n=199) | MeVO (n=43) | P value comparing cohorts | Univariate OR 90-day mRS | P value 90-day mRS | Multivariate OR 90-day mRS | P value 90-day mRS | |
| Age, years (n=242) | 71.3 | 76.1 | 0.25 | 1.81 (1.13 to 2.88) | 0.01 | 2.45 (1.21 to 4.99) | 0.01 |
| Gender (n=242) | 199 | 43 | 0.09 | 1.81 (0.98 to 3.35) | 0.06 | 1.17 (0.50 to 2.76) | 0.72 |
| Men | 98 (49.2%) | 15 (34.8%) | |||||
| Women | 101 (50.8%) | 28 (65.1%) | |||||
| ASPECTS (n=232) | 191 | 41 | 0.07 | 0.11 (0.02 to 0.50) | <0.01 | 0.16 (0.02 to 1.43) | 0.1 |
| 7–10 | 161 (84.3%) | 39 (95.1%) | |||||
| 0–6 | 30 (15.7%) | 2 (4.9%) | |||||
| EVT performed (n=242) | 166 (83.4%) | 33 (76.7%) | 0.31 | 0.72 (0.32 to 1.59) | 0.42 | ||
| OTG (n=228) | 187 | 41 | 0.43 | 1.64 (0.83 to 3.3) | 0.15 | ||
| <6 hours | 126 (67.4%) | 25 (61.0%) | |||||
| >6 hours | 61 (32.6%) | 16 (39.0%) | |||||
| GTR (n=179) | 149 | 30 | 0.29 | 1.93 (0.94 to 3.98) | 0.07 | 1.31 (0.55 to 3.14) | 0.54 |
| <30 min recanalization | 90 (60.4%) | 15 (50.0%) | 1.61 (0.80 to 3.25) | 0.18 | |||
| >30 min recanalization | 59 (39.6%) | 15 (50.0%) | |||||
| r-tPA | 198 | 43 | 0.52 | 0.25 (0.13 to 0.50) | <0.01 | 0.28 (0.11 to 0.69) | 0.01 |
| Yes | 112 (56.6%) | 22 (51.2%) | |||||
| No | 86 (43.4%) | 21 (48.8%) | |||||
| TICI (n=240) | 197 | 43 | 0.12 | 0.86 (0.68 to 1.09) | 0.2 | ||
| Successful (2b–3) | 143 (72.6%) | 26 (60.5%) | |||||
| Unsuccessful (0–2a) | 54 (27.4%) | 17 (39.5%) | |||||
| Post-EVT ICH (n=237) | 89 (44.9%) | 16 (37.2%) | 0.3 | 0.30 (0.15 to 0.58) | <0.01 | ||
| Type of ICH (n=237) | 194 | 43 | 0.39 | 2.98 (1.66 to 5.35) | <0.01 | 1.98 (0.97 to 4.05) | 0.06 |
| No ICH | 105 (54.1%) | 28 (65.1%) | |||||
| Non-severe | 73 (37.6%) | 13 (30.2%) | |||||
| Severe | 16 (8.3%) | 2 (4.7%) | |||||
| EVT complications (n=242) | 12 (6.1%) | 0 | 0.1 | 0.80 (0.15 to 4.3) | 0.79 | ||
| Infarct size (n=237) | 195 | 42 | <0.01 | 2.00 (1.47 to 2.73) | <0.01 | 1.63 (1.08 to 2.48) | 0.02 |
| None | 17 (8.7%) | 3 (7.1%) | |||||
| <1/3 | 114 (58.4%) | 25 (59.5%) | |||||
| >1/3 and <2/3 | 22 (11.2%) | 12 (28.6%) | |||||
| >2/3 | 42 (21.5%) | 2 (4.8%) | |||||
| 90-day mRS (n=195) | 158 | 37 | 0.19 | ||||
| 0–2 | 52 (32.9%) | 10 (27.0%) | |||||
| 3–5 | 52 (32.9%) | 18 (48.7%) | |||||
| 6 | 54 (34.2%) | 9 (24.3%) |
this was supposed to be part of the title of Table 3
ASPECTS, Alberta Stroke Program Early CT Score; EVT, endovascular thrombectomy; GTR, groin puncture to recanalization time; ICH, intracranial hemorrhage; LVO, large vessel occlusion; MeVO, medium vessel occlusion; mRS, modified Rankin score; OTG, symptom onset to groin puncture time; r-tPA, recombinant tissue plasminogen activator; TICI, Thrombolysis in Cerebral Infarction.